PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'4th Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.\', \'2nd Department of Internal Medicine, Democritus University of Thrace, Medical School, Alexandroupolis, Greece.\', \'1st Department of Internal Medicine, Aristotle University ofThessaloniki, Thessaloniki, Greece.\', \'Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece.\', \'3rd Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.\', \'1st Department of Internal Medicine,University of Ioannina, School of HealthSciences, Faculty of Medicine, Ioannina, Greece.\', \'Department of Pulmonary Medicine, General Hospital of Kerkyra, Kerkyra, Greece.\', \'Department of Internal Medicine, University of Patras, Medical School, Rion, Greece.\', \'Department of Internal Medicine and Center for Infectious Diseases, Radboud University, Nijmegen, Netherlands.\', \'Clinical Research Centre, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.\', \'Immunology and Metabolism, Life & Medical Sciences Institute, University of Bonn, Bonn, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.7554/eLife.66125e66125
?:doi
?:hasPublicationType
?:journal
  • eLife
is ?:pmid of
?:pmid
?:pmid
  • 33682678
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.121
?:rankingScore_hIndex
  • 74
is ?:relation_isRelatedTo_publication of
?:title
  • An open label trial of anakinra to prevent respiratory failure in COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all